⚠️Caution - High strength MDMA pills in circulation (Zeus). Found to contain ~2-3x a common adult dose of MDMA (~250-315mg).
There has been an increased number of hospitalisations and reports of MDMA-linked deaths nationwide in recent weeks.
#GoSlowStayLow#LoopAlert ♾
New meta-analysis looking at the effectiveness of universal preventive interventions for severe mental disorders https://t.co/eaD0NajrsJ
Key message: evidence is limited. Universal approaches should be used alongside selective and indicated approaches, not alone.
🧵⬇️
Excellent talk from @Dom__Oliver on using genetic and environmental risk factors to predict outcomes in people at Clinical High Risk of Psychosis at #SIRS2022
📣 PhD Student @S_CoronadoM discusses her thesis and a brand new #harmreduction intervention aimed at people with #psychosis who use #cannabis with @WeAreBarod 🌿
🎧To listen 👇
https://t.co/rwbR7JCB7b
Want to do a PhD using machine learning to develop dynamic models to identify people at risk of developing severe mental disorders? Check out CO24-023 (with @daniel_stahl_01, Paolo Fusar-Poli and I). https://t.co/EJyBk1AHNv… Deadline 1st April. Happy to chat if interested
Apply for a fully funded #PhD to work with James Rucker and me @KingsIoPPN on the anxiolytic effects of CBMPs using experimental medicine and observational datasets https://t.co/D552OJOBVY
🗣️Gabriel Bastien, PhD Candidate, explores the link between substance use, #depression, and #suicide risk 🌱
➡️Watch the full presentation: https://t.co/kb3z97OTpq (French with auto-generated English subs)
#SuicidePreventionWeek
📣 New publication in @APSAD_DAR by Fischer et al.: Three noteworthy idiosyncrasies related to Canada's #opioid-death crisis, and implications for #publichealth oriented interventions 🇨🇦
For more info 👉 https://t.co/ykRw95Z8z4
📣 Nouvelle publication dans @APSAD_DAR par Fischer et al.: Trois particularités remarquables liées à la crise des décès par #opioïdes au Canada et leurs implications pour les interventions de #santépublique 🇨🇦
Plus d’infos 👉 https://t.co/ykRw95ZGoC
💡 Recommendations for safer #cannabis use in psychosis: evidence-based advice to reduce psychotic risks. For consumers, individuals at risk of #psychosis, and healthcare professionals 🌿
▶️ More info: https://t.co/9SpNbSrtSt
💡A new study by @HBakouni27959 et al. published by @JAM_ASAM: The impact of methadone and buprenorphine/naloxone titration patterns on retention and #opioid use in individuals with prescription opioid use disorders: OPTIMA Study
➡️ For more info: https://t.co/wlb4N1TXTM
“There’s a conference on, abstract submission deadline is tomorrow though”
“Impossible, I don’t even have an idea for a…”
“It’s in Italy”
“I’ll have it over to you in 11 seconds”
Discussion sur l’#automédication et le #cannabis : Les mythes et les réalités sur l’utilisation médicale du #cannabis 🍃
🎧Écoutez le segment avec @Penelopemcquade @RadioCanadaInfo : https://t.co/Ihi1oSK210
@pschofie79 Person who knows stuff should be a tenured position, and they would be the most valuable person in any department aside from the admin team